Literature DB >> 8815592

Thrombosis in cancer patients treated with hematopoietic growth factors--a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH.

T Barbui1, G Finazzi, A Grassi, R Marchioli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8815592

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

Review 1.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 2.  Pathogenesis of thrombosis in patients with malignancy.

Authors:  A Falanga; M B Donati
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 3.  Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.

Authors:  Julia Bohlius; Christine Herbst; Marcel Reiser; Guido Schwarzer; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 4.  Drug-induced thrombosis: an update.

Authors:  Yuval Ramot; Abraham Nyska; Galia Spectre
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

Review 5.  Assessing risk of venous thromboembolism in the patient with cancer.

Authors:  Alok A Khorana; Gregory C Connolly
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

Review 6.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

7.  Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimen.

Authors:  J R Murren; A Gollerkeri; S Anderson; S Lutzker; S Del Prete; D Zelterman; L Garrison; B Smith
Journal:  Yale J Biol Med       Date:  1998 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.